Contact us
 |
[email protected] |
 |
3275638434 |
 |
 |
| Paper Publishing WeChat |
Useful Links
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Article
Importance of Pharmacoeconomics in the Pharmacovigilance for National Health Systems
Author(s)
Manuel Miguel Collazo Herrera and Leslie Pérez Ruiz
Full-Text PDF
XML 1307 Views
DOI:10.17265/2328-2150/2017.02.003
Affiliation(s)
ABSTRACT
The objective of this study is to conduct a literature
review to assess the importance of pharmacoeconomics in developing
pharmacovigilance activities as a working tool to guide the process of decision
making in the health field. The authors have done a
literature review in order to find information about pharmacovigilance and
their relationship with the pharmacoeconomics field, as an important element to
assess the economic and health consequences because of the use of drugs in
health systems. From this study, it can be found that pharmacoeconomics
applied to the pharmacovigilance activities should be considered as an aspect
that contributes to improving the rational use of medicines, because it allows
to compare the costs and consequences (beneficial and detrimental) with the use
of different pharmacotherapeutic alternatives, in order to assess the negative
effects due to ADRs (adverse
drug reactions), which directly increase the morbidity and mortality in
patients, increase the direct health costs and indirectly decrease the
productivity labors. It
can be also concluded that
pharmacoeconomics constitutes an important aspect to the pharmacovigilance activity
in the health systems, in
order to evaluate the negative impact of ADR, both on patient health as its
economic implications, due to associated costs with these adverse effects.
KEYWORDS
Pharmacoeconomics, pharmacovigilance, adverse drug reaction, health costs.
Cite this paper
Herrera, M. M. C., and Ruiz, L. P. 2017. “Importance of Pharmacoeconomics in the Pharmacovigilance for National Health Systems.” Journal of Pharmacy and Pharmacology 5 (2): 79-84.
References